cropped-Website-Logo.png

Globela Pharma Pvt Ltd.

  • About
    • Journey and Achievements
    • Purpose and Approach
    • Globela Team and Events
  • Products & Services
  • Our Capabilities
  • Collaborate
  • Globela Group
  • Corp. Gov & Responsibility
  • Careers
  • Contact
    • Global/English
    • Spanish
    • French
    • Russian

Home

Monthly Archives: January 2025

IMG_0838

Green Synthesis Advances in Active Pharmaceutical Ingredients (APIs): A Sustainable Approach to Pharmaceutical Production 

January 31, 2025
by Globela Globela Pharma

In the present era, the pharmaceutical companies are facing repetitive pressure to adopt sustainable and environmentally friendly practices. As we are the part of society that is highly concerned about climate change, resource depletion, and the impact o ...

Read More
IMG_0839

Diffused Compressible Granules (DCGs): The Game Changer for Sustainable Practices 

January 31, 2025
by Globela Globela Pharma

In the present era, the pharmaceutical industry produces oral solid dosage like tablets, which is indeed a critical aspect of drug formulation. There are different excipients that are used to facilitate the manufacturing of these dosage forms. Among all ...

Read More
Global Regulatory Collaboration

Collaboration- A need of hour to Speed up Access to New Vaccines

January 13, 2025
by Globela Globela Pharma

Introduction: The fatal wave of COVID-19 made everyone aware of the importance of vaccines to prevent and control tremendously dangerous and infectious diseases. The whole world during the COVID-19 pandemic needed an efficient vaccine to kill the viru ...

Read More
Biopharma_manufracturing

The future of Biopharma Manufacturing with Digital Advances

January 13, 2025
by Globela Globela Pharma

Introduction  The biopharma industry is on a transformative path where digitalization is fundamentally changing the whole scenario of manufacturing. As per the present time, the demand of innovative therapies is increasing, coupled with pressure ...

Read More
revised_blog

The Role of CROs in Accelerating Oncology Drug Development

January 13, 2025
by Globela Globela Pharma

Introduction  In the present era, the pharmaceutical and biotech industries have seen a noticeable and remarkable transformation in the field of oncology. New innovations and technologies in cancer treatment, including immunotherapies, targeted t ...

Read More
  • Analgesic
  • Anthelmintic
  • Anti Allergic
  • Anti bacterial
  • Anti Cold
  • Anti Diabetics
  • Anti Malarial
  • Antifungal
  • Antipsychotic & CNS
  • Antispasmodics
  • ARV - Antiretroviral
  • Cardiovascular Drugs
  • Cephalosporins & Betalactam
  • Electrolytes
  • Erectile Dysfunction
  • Gastrology
  • Immunosuppressant
  • Laxative
  • Nephrology
  • Oncology
  • Steroidal Anti Inflammatory
  • Urology
  • Vitamins and Minerals
cropped-Website-Logo.png

Globela Pharma Pvt Ltd.

Globela Pharma, a EU GMP, WHO GMP, ISO Certified, MNC Accredited company, is a leading manufacturer of quality pharmaceutical products with in 50+ nations around the world with expertise in R&D and a passion for innovation aligned with the industry’s gold standards to ensure high quality products made affordable.

  • Plot No. 357&358 Road Number 3 Near Ginza Industries, GIDC, Sachin, Surat, Gujarat 394230

Quick Links

  • Therapeutic Areas
  • R & D
  • Collaboration
  • CRAMS
  • API
  • Intermediates
  • Awards
  • Event Gallery
  • Worldwide Locations

Our Company

  • About
  • Our Capabilities
  • Globela Group
  • Case Studies
  • Blogs
  • Corp. Gov & Responsibility
  • Careers
  • Latest at Globela
  • Investor Relations

© 2022-23. All rights reserved.

Facebook Instagram Linkedin
Shopping Basket

WhatsApp us

Download DC Granules & Pellets List PDF

Enter your name and email to download PDF.

Name
Enter your email address

Thanks, I’m not interested

Download Intermediates List PDF

Enter your name and email to download PDF.

Name
Enter your email address

Thanks, I’m not interested

Download API List PDF

Enter your name and email to download PDF.

Name
Enter your email address

Thanks, I’m not interested